Christopher C. Woller
Lawyers
Filters
Cryoport $287.5 million follow-on offering
We advised the underwriters on the SEC-registered offering
CytomX Therapeutics $100 million follow-on offering
We advised the joint book-running managers in connection with the equity offering
Editas Medicine $231 million stock offering
We advised the joint book-running managers in connection with the equity offering
Affirm Holdings $1.39 billion IPO
The shares are listed on the Nasdaq Global Select Market
NeoGenomics $230 million stock and $345 million convertible notes offerings
We advised the joint book-running managers on the public offerings of stock and convertible notes
McCormick $710 million acquisition of FONA International
Davis Polk advised McCormick & Company Inc. in connection with its $710 million acquisition of FONA International, LLC. The transaction is subject to customary working capital…
cxLoyalty Group Holdings sale of Global Loyalty division to JPMorgan Chase
Davis Polk is advising cxLoyalty Group Holdings, Inc. in connection with its definitive agreement to sell its Global Loyalty division to JPMorgan Chase & Co. The deal includes cxLoyalty…
Comcast subsidiary FreeWheel acquires BeeswaxIO
Davis Polk is advising FreeWheel, a subsidiary of Comcast Corporation, on its acquisition of BeeswaxIO Corporation. Financial terms of the deal were not disclosed.
FreeWheel, a Comcast…
Hydrofarm Holdings Group $199 million IPO
Davis Polk advised the representatives of the underwriters in connection with the $199 million initial public offering of 9,966,667 shares of common stock of Hydrofarm Holdings…
FuelCell Energy $258 million follow-on and secondary offering
Davis Polk advised the representative of the several underwriters in connection with the $258 million offering of 39,696,320 shares of FuelCell Energy, Inc.’s common stock, which…